English  |  正體中文  |  简体中文  |  Total items :2856704  
Visitors :  53731212    Online Users :  1008
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"yu h c"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 16-25 of 126  (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T01:53:57Z Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:51Z Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma Yu H.-C.; Chen H.-J.; Chang Y.-L.; Liu C.-Y.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.
臺大學術典藏 2021-09-01T01:53:50Z Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome Yu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.
臺大學術典藏 2021-08-31T06:29:33Z Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen Chen I.-C.; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; Lin C.-H.; Wei-Wu Chen T.; ANN-LII CHENG; Lu Y.-S.
臺大學術典藏 2021-08-16T03:26:38Z Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen I-CHUN CHEN; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; Lin C.-H.; Wei-Wu Chen T.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-07-16T06:18:16Z Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation Chen K.-F.; Yu H.-C.; Liu T.-H.; SHOEI-SHENG LEE; Chen P.-J.; Cheng A.-L.
臺大學術典藏 2021-07-06T02:04:11Z STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma Tai W.-T.; Chu P.-Y.; Shiau C.-W.; Chen Y.-L.; Li Y.-S.; Hung M.-H.; Chen L.-J.; PEI-LUNG CHEN; Su J.-C.; Lin P.-Y.; Yu H.-C.; Chen K.-F.
臺大學術典藏 2021-07-03T03:34:45Z Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:40Z CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:38Z Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.

Showing items 16-25 of 126  (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page